<?xml version="1.0" encoding="UTF-8"?>
<svg height="777.49" width="545.202" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M49.610 53.720 L532.910 53.720 "/>
  <g begin="text">
   <text y="49.34" x="49.606,54.606,59.606,64.606" svgx:width="0.5,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">466 </text>
   <text y="49.34" x="438.646,443.126,447.606,451.146,453.956,458.336,461.466,464.246,468.826,473.206,476.746,480.286,482.166,486.646,491.336,494.116,499.326,501.306,504.086,509.296,514.506,517.286,520.206,524.786,529.996" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1)</text>
  </g>
  <g begin="text">
   <text y="767.49" x="49.606,57.736,62.426,64.306,67.116,68.996,73.896,75.776,80.156,82.936,87.516,91.366,93.246,97.626,100.756,105.236,108.776,110.656,114.196,116.976,119.376,123.856,128.546,131.676,136.366,141.056" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="767.49" x="142.936,145.716,150.716,155.716,160.716,165.716,167.906,170.686,175.686,180.686,182.876,185.656,188.886,193.466,198.466,201.696,204.476,209.476,214.476,219.476,224.476,229.476,234.476" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="767.42" x="466.181,473.891,477.741,479.931,482.121,485.971,490.241,494.511,499.301,504.301,509.301,514.201,516.391,520.771,526.291" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M49.610 122.160 L82.350 122.160 "/>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M49.610 671.160 L81.360 671.160 "/>
  <g begin="text">
   <text y="76.959" x="49.606,55.105,59.605,64.105" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P911</text>
   <text y="87.957" x="49.606,56.104,60.1,63.097,67.597,70.099,72.601,76.597,81.601,83.851,87.847,92.851,97.351,101.347,105.847,109.843,112.84,116.836,120.832,123.334,127.33,131.83,134.827,137.329,141.829,146.833,149.083,153.583,156.58,158.83,161.827,166.831,170.827,173.077,177.073,180.07,183.067,187.063,191.059,194.056,197.557,199.807,204.307,207.304,209.554,214.558,218.554,223.054,225.556,230.056,235.06,239.56,243.556,248.56" svgx:width="0.72,0.44,0.33,0.5,0.28,0.28,0.44,0.56,0.25,0.44,0.56,0.5,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.5,0.33,0.28,0.5,0.56,0.25,0.5,0.33,0.25,0.33,0.56,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.33,0.39,0.25,0.5,0.33,0.25,0.56,0.44,0.5,0.28,0.5,0.56,0.5,0.44,0.56,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Detailed characterization of the effects of prolonged-</text>
   <text y="98.955" x="49.606,53.602,57.598,60.1,64.096,68.596,72.097,76.093,78.343,81.34,85.84,93.337,98.341,102.337,104.839,109.843,112.345,117.349,121.345,123.595,128.095,133.099,135.349,141.847,146.347,148.849,153.853,156.355,161.359,165.859,168.109,171.106,176.11,181.114,185.11,188.107,190.609,195.109,200.113,202.363,204.865,209.869,212.119,217.123,221.623,224.62,227.122,231.118,236.122,239.119,242.62,244.87,251.368,253.87,256.867,261.871" svgx:width="0.44,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.33,0.5,0.83,0.56,0.44,0.28,0.56,0.28,0.56,0.44,0.25,0.5,0.56,0.25,0.72,0.5,0.28,0.56,0.28,0.56,0.5,0.25,0.33,0.56,0.56,0.44,0.33,0.28,0.5,0.56,0.25,0.28,0.56,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.25,0.72,0.28,0.33,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">release fampridine on walking function in patients with </text>
   <text y="109.953" x="49.606,57.103,62.107,64.609,67.606,70.108,75.112,77.614,81.61,83.86,87.361,91.357,93.859,97.855,101.851,106.351,109.852,112.354,115.855,118.105,121.102,126.601,133.099,141.595,147.094,154.096,157.597,164.095" svgx:width="0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.25,0.33,0.61,0.72,0.94,0.61,0.78,0.39,0.72,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">multiple sclerosis (FAMPKIN)</text>
   <text y="120.951" x="49.606,55.609,57.859,63.358,67.858,70.855,75.355,79.351" svgx:width="0.67,0.25,0.61,0.5,0.33,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">B Zörner</text>
   <text y="118.439" x="82.348" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="120.959" x="85.273,87.523,89.773,96.271,98.521,104.524,108.52,113.02,115.522,119.518" svgx:width="0.25,0.25,0.72,0.25,0.67,0.44,0.5,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, K Reuter</text>
   <text y="118.439" x="122.514" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="120.959" x="125.439,127.689,129.939,135.438,137.688,142.692,145.194,147.696,150.198" svgx:width="0.25,0.25,0.61,0.25,0.56,0.28,0.28,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, L Filli</text>
   <text y="118.439" x="152.7" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="120.959" x="155.625,157.875,160.125,165.624,167.874,173.373,177.873,180.87,183.372,187.872,191.868" svgx:width="0.25,0.25,0.61,0.25,0.61,0.5,0.33,0.28,0.5,0.44,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, L Lörincz</text>
   <text y="118.439" x="195.864" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="120.959" x="198.789,201.039,203.289,209.787,212.037,220.533,224.529,227.031,229.533,233.529" svgx:width="0.25,0.25,0.72,0.25,0.94,0.44,0.28,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Weller</text>
   <text y="118.439" x="236.525" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="120.959" x="239.45,241.7,243.95,249.449" svgx:width="0.25,0.25,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T </text>
   <text y="131.957" x="49.604,54.608,59.108,61.61,64.112,68.108" svgx:width="0.56,0.5,0.28,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Sutter</text>
   <text y="129.439" x="71.107" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="131.959" x="74.032,76.282,78.532,86.533,88.783,93.787,97.783,100.78,105.28,109.276" svgx:width="0.25,0.25,0.89,0.25,0.56,0.44,0.33,0.5,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Farkas</text>
   <text y="129.439" x="112.777" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="131.959" x="115.702,117.952,120.202,125.206,127.456,133.954,137.95,142.45,144.952,147.454,151.45" svgx:width="0.25,0.25,0.56,0.25,0.72,0.44,0.5,0.28,0.28,0.44,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Kapitza</text>
   <text y="129.439" x="155.445" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="131.959" x="158.37,160.62,162.87,170.871,173.121,178.62,181.122,185.622,190.122,194.118,198.618,202.614,207.114" svgx:width="0.25,0.25,0.89,0.25,0.61,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Linnebank</text>
   <text y="129.439" x="211.614" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="140.437" x="49.604" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="142.959" x="52.531,59.029,63.529,66.031,70.027,74.023,77.524,81.025,83.527,86.029,90.025,92.275,98.773,103.273,106.774,111.274,113.776,116.278,120.778,123.28,125.53,130.534,135.034,138.535,141.037,145.033,149.533,151.783,154.033,160.531,164.527,169.027,173.527,177.028,179.53,186.028,190.024,194.524,197.026,199.276,203.776,206.278,208.528,214.531,218.527,223.027,226.528,231.028,233.53,238.03,242.53,246.526,248.776,251.026,256.03,260.53,264.031,266.533,270.529,275.029,277.279" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.56,0.5,0.39,0.28,0.44,0.5,0.25,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.56,0.5,0.39,0.28,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University Hospital Zurich, Department of Neurology, Zurich, </text>
   <text y="153.957" x="49.606,54.106,60.109,62.611,65.113,68.614,72.61,76.111,78.613,83.113,87.613" svgx:width="0.5,0.67,0.28,0.28,0.39,0.44,0.39,0.28,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Switzerland</text>
   <text y="180.957" x="49.606,55.609,60.109,64.105,69.109,73.609,77.443,81.943,86.947,91.951,96.955,99.952" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="180.957" x="102.706,108.709,112.705,116.701,120.697,125.197,127.699,130.453,133.954,136.456,140.956,145.456,147.958,151.954,155.455,158.209,162.709,166.705,173.707,178.207,182.707,186.208,188.71,191.707,195.703,198.205,202.201,206.701,209.455,211.957,216.457,220.453,223.207,227.707,231.703,236.203,240.199,243.196,245.698,249.694,252.196,256.192,258.694,261.448,265.444,268.279,271.276,275.272,279.268,281.77,285.271" svgx:width="0.67,0.44,0.44,0.44,0.5,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.5,0.44,0.78,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.5,0.44,0.33,0.28,0.44,0.28,0.44,0.28,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Recent studies demonstrated the beneficial effects </text>
   <text y="191.955" x="49.606,54.106,57.103,59.353,60.46,63.457,67.453,74.455,78.955,81.952,84.454,88.954,91.456,95.956,99.952,102.202,103.309,106.306,110.806,113.803,117.799,124.801,127.303,131.803,136.303,140.803,145.303,148.3,150.802,155.302,157.804,162.304,166.3,169.297,171.547,172.654,177.154,181.654,183.904,185.011,189.511,193.507,196.009,198.511,200.761,201.868,206.368,210.364,212.866,217.366,221.362,223.864,226.366,230.866,233.116,234.223,236.725,241.225,243.475,244.582,248.578,250.828,251.935,255.436,259.936,264.436,267.937,271.933,274.435,276.685,277.792,282.292,285.289" svgx:width="0.5,0.33,0.25,0.55,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.33,0.44,0.78,0.28,0.5,0.5,0.5,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.25,0.55,0.5,0.44,0.28,0.5,0.44,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.39,0.5,0.5,0.39,0.44,0.28,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of fampridine (4-aminopyridine) on gait velocity in a subset of </text>
   <text y="202.953" x="49.606,54.106,58.102,60.604,63.106,67.102,71.602,74.104,77.605,79.738,86.236,88.738,91.24,95.74,97.873,104.875,109.375,111.877,114.379,116.881,121.381,123.883,127.879,130.012,133.513,137.509,140.011,144.007,147.004,151.504,155.005,157.507,161.008,163.141,166.138,174.139,179.143,182.14,184.39,186.523,191.527,195.523,202.525,207.025,210.022,212.524,217.024,219.526,224.026,228.022,230.155,234.655,237.157,241.657,245.653,250.153,253.654,255.787,260.287,264.787,267.289,269.791,273.787,278.287,282.283" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.25,0.56,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.5,0.28,0.5,0.44,0.5,0.39,0.25,0.5,0.5,0.28,0.28,0.44,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients with multiple sclerosis (MS). Fampridine blocks voltage-</text>
   <text y="213.951" x="49.606,54.106,58.102,60.604,64.6,69.1,71.845,76.345,80.845,83.347,87.343,90.844,94.345,96.847,101.347,108.349,111.085,115.081,119.581,123.577,128.077,132.577,136.573,139.075,142.576,145.312,147.814,151.81,155.806,160.306,162.808,167.308,171.808,174.553,177.055,181.555,184.291,188.287,192.787,197.287,201.283,205.783,209.779,213.775,218.275,221.011,224.512,227.014,231.514,236.014,240.01,242.512,245.257,249.253,253.753,258.253,262.753,267.253,271.249,273.751,276.253,280.753,285.253" svgx:width="0.5,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.28,0.44,0.39,0.39,0.28,0.5,0.78,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.28,0.39,0.25,0.28,0.44,0.44,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.25,0.39,0.28,0.5,0.5,0.44,0.28,0.25,0.44,0.5,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">gated potassium channels leading to enhanced signal conduction </text>
   <text y="224.949" x="49.606,52.108,56.608,58.858,63.358,67.354,74.356,78.856,82.852,85.354,87.856,92.356,96.352,98.854,102.85,107.35,109.6,114.1,118.096,121.093,125.593,129.589,131.839,134.836,137.338,141.838,145.834,148.831,152.332" svgx:width="0.28,0.5,0.25,0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.33,0.5,0.44,0.25,0.33,0.28,0.5,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in demyelinated nerve fibers.</text>
   <text y="235.947" x="49.606,56.608,61.612,64.609,68.605,72.601,75.598,78.1,82.6,86.596,90.097,93.094" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="235.947" x="94.912,100.411,104.911,108.907,110.725,115.063,121.561,129.562,134.566,141.064,144.061,150.559,152.377,155.878,158.38,162.88,167.38,171.88,173.698,176.695,181.195,183.697,186.199,190.699,193.201,195.703,198.205,202.201,204.703,207.205,211.705,214.207,218.203,222.199,224.701,227.203,230.2,232.702,236.698,239.2,242.701,244.951,249.451,253.951,258.451,261.448,263.266,267.262,269.764,276.766,280.762,285.262" svgx:width="0.61,0.5,0.44,0.25,0.56,0.72,0.89,0.56,0.72,0.33,0.72,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.33,0.5,0.28,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.5,0.5,0.5,0.33,0.25,0.44,0.28,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The FAMPKIN study (http://clinicaltrials.gov) aimed </text>
   <text y="246.945" x="49.606,52.108,56.608,58.858,59.74,63.736,68.236,72.232,75.229,79.225,83.221,85.723,89.719,92.716,95.218,99.214,103.21,105.46,106.333,108.835,113.335,117.331,119.581,120.463,124.459,127.294,130.291,134.287,138.283,140.785,144.286,146.536,147.409,151.909,154.906,157.156,158.038,162.538,165.535,170.035,172.537,177.037,181.537,186.037,190.033,194.533,197.53,200.527,204.523,207.025,211.021,215.017,218.518,222.514,224.764,225.637,228.634,233.638,239.641,242.638,244.888,245.761,248.758,252.754,259.756,264.256,267.253,269.755,274.255,276.757,281.257,285.253" svgx:width="0.28,0.5,0.25,0.55,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.28,0.44,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.33,0.5,0.28,0.5,0.5,0.5,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.25,0.55,0.33,0.56,0.67,0.33,0.25,0.55,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to characterize the effects of prolonged-release (PR) fampridine </text>
   <text y="257.943" x="49.606,54.106,58.606,61.513,66.013,68.515,71.35,74.347,78.343,81.34,85.336,89.836,92.338,95.245,102.247,106.747,111.247,115.243,117.745,120.247,122.749,125.251,129.247,132.748,135.655,140.155,143.152,146.059,150.055,157.057,161.557,166.057,168.559,172.555,175.057,179.557,182.554,187.054,189.961,192.958,197.458,201.958,205.954,208.456,210.958,215.458,219.958,222.865,225.367,229.867,233.863,236.365,240.865,245.365,247.867,252.367,256.867,259.774,266.776,271.276,274.777,278.773,281.275,285.271" svgx:width="0.5,0.5,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.78,0.5,0.5,0.44,0.28,0.28,0.28,0.28,0.44,0.39,0.25,0.5,0.33,0.25,0.44,0.78,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.78,0.5,0.39,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">on different modalities of ambulatory function including muscle </text>
   <text y="268.941" x="49.606,53.107,55.609,58.606,62.602,67.102,71.602,74.104,78.604,80.854,83.104,85.327,88.828,91.33,95.326,99.826,102.328,104.83,107.332,109.834,114.334,116.584,118.807,122.803,127.303,131.803,134.053,136.276,140.272,144.772,149.272,152.269,156.769,159.271,163.771,167.767,170.269,172.771,177.271,181.771,184.021,186.271,188.494,192.832,199.33,207.331,212.335,218.833,221.83,228.328,230.578,232.801,237.301,241.297,244.798,247.3,251.8,256.3,260.296,264.796,267.046,269.269,273.265,276.766,279.016,281.239,285.235" svgx:width="0.39,0.28,0.33,0.44,0.5,0.5,0.28,0.5,0.25,0.25,0.55,0.39,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.5,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.56,0.72,0.89,0.56,0.72,0.33,0.72,0.25,0.55,0.5,0.44,0.39,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">strength, stability and coordination. FAMPKIN designed as a </text>
   <text y="279.939" x="49.606,54.106,58.606,62.602,66.103,70.099,72.466,75.463,78.46,80.71,83.077,87.577,92.077,96.577,101.077,103.579,107.575,110.572,115.072,117.574,120.076,124.576,129.076,131.326,133.693,136.69,140.686,145.186,149.686,154.186,161.188,163.69,167.686,171.682,176.182,178.549,182.545,187.045,191.545,193.912,198.412,200.914,204.91,208.906,212.902,217.402,221.902,224.899,228.895,233.395,237.895,240.397,243.394,247.894,250.396,252.898,256.894,261.394,263.761,267.757,270.754,275.254,278.755,282.256" svgx:width="0.5,0.5,0.44,0.39,0.44,0.25,0.33,0.33,0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.33,0.5,0.28,0.28,0.5,0.5,0.25,0.25,0.33,0.44,0.5,0.5,0.5,0.78,0.28,0.44,0.44,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.33,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.44,0.33,0.5,0.39,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">phase II, double-blind, randomized and placebo-controlled cross-</text>
   <text y="290.937" x="49.606,54.106,58.606,62.602,65.599,67.624,71.125,73.627,78.127,82.627,87.127,89.152,93.148,96.649,100.15,104.146,107.647,111.148,115.144,119.644,121.669,126.169,130.165,132.667,135.169,137.194,140.191,144.691,149.191,153.187,155.689,158.191,162.691,167.191,169.216,173.716,178.216,181.213,183.715,188.215,192.715,194.74,197.242,203.74,208.24,210.265,214.765,219.265,223.765,228.265,230.767,234.763,237.76,242.26,244.762,247.264,251.764,256.264,258.289,261.286,265.282,272.284,276.784,279.781,282.283" svgx:width="0.5,0.5,0.44,0.33,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.72,0.5,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.33,0.5,0.28,0.28,0.5,0.5,0.25,0.33,0.44,0.78,0.5,0.33,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">over study assessed gait function during two double-blind fampri-</text>
   <text y="301.935" x="49.606,54.106,56.608,61.108,65.104,67.354,71.854,74.851,77.101,81.601,84.103,88.099,92.095,96.091,100.591,105.091,107.341,109.843,112.84,116.836,120.832,123.334,130.336,134.332,138.832,141.334,143.584,148.084,152.584,156.58,160.081,164.077,167.578,169.828,172.825,176.821,180.817,184.813,189.313,191.563,196.063,198.313,204.811,208.807,212.803,217.303,220.804,223.801" svgx:width="0.5,0.28,0.5,0.44,0.25,0.5,0.33,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.5,0.44,0.39,0.44,0.39,0.25,0.33,0.44,0.44,0.44,0.5,0.25,0.5,0.25,0.72,0.44,0.44,0.5,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">dine or placebo treatment phases (each 6 weeks).</text>
   <text y="312.933" x="49.606,58.102,62.098,65.095,70.099,74.599,79.603,83.104,86.101" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="312.933" x="88.432,96.208,100.204,102.706,107.206,109.708,114.208,118.708,121.039,127.537,131.533,135.034,137.365,139.867,144.367,148.867,152.863,156.364,158.866,161.368,165.868,169.864,172.366,176.362,180.862,183.193,187.693,191.194,193.696,198.196,202.696,205.027,209.527,212.029,214.864,217.861,221.857,224.854,228.85,233.35,235.852,238.183,242.179,244.681,247.183,251.683,254.185,258.181,262.177,264.679,267.01,269.512,273.508,277.009,279.511,283.012,285.262" svgx:width="0.94,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.44,0.39,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Walking was investigated using different clinical tests, </text>
   <text y="323.931" x="49.606,54.151,58.696,62.737,66.283,68.83,71.377,75.922,80.467,85.012,89.053,91.6,94.642,98.683,102.229,104.479,106.045,110.086,114.631,119.176,121.426,122.992,127.537,131.578,134.125,138.166,140.713,143.26,147.301,151.846,154.096,155.662,160.207,162.754,167.299,171.34,178.387,182.428,184.975,187.522,191.563,194.605,199.15,201.697,206.242,210.283,212.83,215.377,219.418,221.668,223.234,227.779,231.82,234.367,236.914,239.164,240.73,244.771,249.316,253.357,255.904,260.449,263.995,266.542,270.088,272.383,274.633,276.199,280.744,285.244" svgx:width="0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.78,0.44,0.28,0.28,0.44,0.33,0.5,0.28,0.5,0.44,0.28,0.28,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">questionnaires and detailed kinematic-kinetic gait analysis. 55 </text>
   <text y="334.929" x="49.606,54.151,58.192,60.739,63.286,67.327,71.872,74.419,77.965,80.215,84.787,91.33,93.877,96.424,100.969,103.219,107.791,110.833,114.874,117.421,121.462,126.007,129.553,132.1,136.645,141.19,144.232,147.274,151.315,158.362,160.909,163.456,166.003,168.55,173.095,177.64,179.935,182.185,186.757,191.302,194.344,196.891,203.938,207.979,211.021,215.566,218.608,220.858,225.43,229.471,234.016,238.561,240.811,245.383,248.929,252.97,257.011,261.556,266.101,270.646,274.687,277.729,282.274,285.262" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.33,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.5,0.33,0.28,0.78,0.44,0.33,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.44,0.44,0.5,0.5,0.5,0.44,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients with relapsing-remitting, primary- and secondary- </text>
   <text y="345.927" x="49.606,54.106,57.103,61.603,66.103,69.1,73.096,76.597,80.098,82.6,87.1,91.096,93.346,94.75,102.751,107.755,110.005,111.409,115.405,119.905,126.907,131.407,133.909,137.905,140.407,144.403,148.903,151.153,152.557,155.059,159.559,163.555,165.805,167.218,170.719,173.221,177.721,182.221,186.721,188.971,190.375,193.372,197.872,202.372,204.622,206.035,212.533,217.033,224.035,228.031,232.531,234.781,237.031,238.435,242.935,247.435,249.685,251.089,258.091,262.087,266.587,269.089,271.339,272.752,276.748,281.248,285.244" svgx:width="0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.89,0.56,0.25,0.55,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.33,0.5,0.5,0.25,0.55,0.72,0.5,0.78,0.44,0.5,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">progressive MS completed the study (34 women, 21 men; age </text>
   <text y="356.925" x="49.606,54.106,58.606,60.856,65.356,68.011,73.087,75.589,78.586,81.241,85.741,87.991,92.491,95.146,99.646,103.642,107.638,110.635,114.136,116.638,119.293,126.295,130.291,134.791,137.293,141.289,145.789,148.444,153.943,160.441,165.445,170.449,173.104,178.18,180.835,185.335,187.585,192.085,195.082,197.332,199.987,204.991,208.987,211.489,213.991,217.987,222.487,224.989,228.49,231.145,237.643,241.639,244.636,248.632,251.287,255.283,257.785,261.781,265.282,268.783,271.285,274.282,276.784,280.78,285.28" svgx:width="0.5,0.5,0.25,0.5,0.25,0.56,0.28,0.33,0.25,0.5,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.28,0.25,0.78,0.44,0.5,0.28,0.44,0.5,0.25,0.61,0.72,0.56,0.56,0.25,0.56,0.25,0.5,0.25,0.5,0.33,0.25,0.25,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.28,0.44,0.39,0.39,0.28,0.33,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">48.4 +/- 9.7 years; median EDSS = 4.5). Patients were classified </text>
   <text y="367.923" x="49.606,52.108,56.608,59.11,63.61,65.464,68.461,72.457,75.958,80.458,84.958,89.458,93.958,97.954,100.951,102.805,106.801,111.301,115.801,117.655,122.155,126.655,131.155,134.152,137.149,141.145,144.646,149.146,153.646,158.146,162.646,166.642,169.639,171.493,175.489,179.485,183.481,187.981,190.978,195.478,197.98,202.48,206.98,208.834,211.336,215.836,217.69,220.192,224.692,228.688,230.542,234.538,237.535,240.037,242.539,246.535,249.532,252.034,256.03,257.884,262.384,265.885,269.881,274.381,276.235,280.735,285.235" svgx:width="0.28,0.5,0.28,0.5,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.33,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.25,0.44,0.44,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.33,0.28,0.28,0.44,0.33,0.28,0.44,0.25,0.5,0.39,0.44,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">into responder and non-responder according to the criteria used by </text>
   <text y="378.921" x="49.606,56.104,60.604,65.104,69.604,76.606,80.602,85.102" svgx:width="0.72,0.5,0.5,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Goodman </text>
   <text y="378.921" x="88.639,92.635,95.137,97.387,98.674,103.174,105.676" svgx:width="0.44,0.28,0.25,0.55,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">et al.</text>
   <text y="378.921" x="107.926,110.176,111.463,114.46,119.959,123.955,128.455,132.451,136.447,138.949,141.199,143.449,144.736,149.236,153.736,158.236,162.736,165.733,167.983,170.233,171.52,176.02,180.52,188.017,190.267,191.554,194.551,199.051,204.127,208.627,213.127,216.124,218.374,219.661,224.161,227.158,229.408,230.695,234.691,237.193,239.695,241.945,243.232,247.732,251.728,254.725,257.227,259.729,263.725,266.227,270.727,274.723,279.223,281.725,285.226" svgx:width="0.25,0.55,0.33,0.61,0.44,0.5,0.44,0.44,0.28,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.5,0.5,0.83,0.25,0.55,0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.28,0.28,0.25,0.55,0.5,0.44,0.33,0.28,0.28,0.44,0.28,0.5,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> (Lancet, 2009). 31% (n=17) of all participants </text>
   <text y="389.919" x="49.606,56.104,60.1,63.097,67.093,69.343,71.17,74.167,78.163,85.165,89.665,92.662,95.164,99.664,102.166,106.666,110.662,113.659,116.656,120.652,124.153,128.653,133.153,137.653,142.153,146.149,148.786,151.036,153.286,155.113,159.613,167.11,169.36,171.187,174.184,178.684,183.76,188.26,191.257,193.507,195.334,201.832,205.828,208.825,212.821,215.071,216.898,221.398,223.9,227.896,231.892,235.888,240.388,244.888,247.885,250.882,254.878,258.379,262.879,267.379,271.879,276.379,280.375,283.012,285.262" svgx:width="0.72,0.44,0.33,0.44,0.25,0.55,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.33,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.25,0.25,0.55,0.5,0.83,0.25,0.55,0.33,0.5,0.56,0.5,0.33,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.33,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were fampridine-responder, 5% (n=3) were placebo-responder, </text>
   <text y="400.917" x="49.606,53.602,58.102,62.602,64.852,69.352,76.849,79.099,82.096,86.596,91.672,96.172,99.169,101.419,108.421,112.417,114.919,117.169,119.671,124.171,128.167,130.417,133.414,137.41,140.911,145.411,149.911,154.411,158.911,162.907,165.904,168.154,172.15,175.147,177.649,180.151,184.147,187.144,189.646,193.642,195.892,198.394,202.894,205.144,209.644,214.144,216.646,221.146,223.396,227.896,232.396,236.392,239.893,243.889,247.39" svgx:width="0.44,0.5,0.5,0.25,0.5,0.83,0.25,0.33,0.5,0.56,0.5,0.33,0.25,0.78,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.25,0.44,0.33,0.28,0.28,0.44,0.33,0.28,0.44,0.25,0.28,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.5,0.5,0.44,0.39,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and 9% (n=5) met the responder criteria in both phases.</text>
   <text y="411.915" x="49.606,56.059,60.01,63.466,68.425,70.882,73.834,77.29,80.242" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="411.915" x="82.006,88.459,92.914,95.866,98.323,102.778,107.233,108.997,111.949,115.9,122.857,127.312,130.264,132.721,137.176,139.633,144.088,148.039,149.803,152.26,155.212,159.163,163.114,165.571,172.528,176.479,180.934,183.391,185.596,187.36,191.815,195.766,198.223,200.68,202.444,206.899,210.85,213.307,217.762,221.713,224.17,226.627,231.082,232.846,235.798,238.255,240.712,247.669,251.62,256.075,259.027,263.482,267.937,270.889,273.841,278.296,282.751,285.253" svgx:width="0.72,0.5,0.33,0.28,0.5,0.5,0.25,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.5,0.44,0.28,0.28,0.25,0.5,0.44,0.28,0.5,0.44,0.28,0.28,0.5,0.25,0.33,0.28,0.28,0.78,0.44,0.5,0.33,0.5,0.5,0.33,0.33,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">During fampridine treatment, gait velocity (timed-25-foot </text>
   <text y="422.913" x="49.606,56.059,60.01,62.467,66.922,69.874,71.8,78.253,82.204,85.66,87.586,90.043,94.498,98.449,101.401,105.352,109.303,112.759,116.71,121.165,123.091,127.546,132.001,133.927,138.382,140.587,145.042,152.494,154.42,156.877,161.332,163.258,165.715,170.17,174.121,176.047,178.504,182.959,185.416,189.367,191.824,193.75,198.205,202.66,207.115,211.57,214.027,217.978,220.435,222.892,227.347,231.802,233.728,236.68,241.135,246.166,250.621,255.076,258.028,260.233,262.159,266.614,271.069,273.274,277.729,285.226" svgx:width="0.72,0.44,0.28,0.5,0.33,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.5,0.5,0.25,0.5,0.25,0.5,0.83,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.25,0.5,0.5,0.25,0.5,0.83,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">walk) was increased by 5.8% in the total population (n=55), 12.3% </text>
   <text y="433.911" x="49.606,52.063,56.518,58.525,60.982,65.437,69.388,71.395,75.85,80.305,83.257,87.208,89.215,92.167,96.118,103.075,107.53,110.482,112.939,117.394,119.851,124.306,128.257,131.209,134.161,138.112,141.568,146.023,150.478,154.933,159.388,163.339,166.291,168.298,171.754,176.209,180.664,185.119,188.071,192.526,196.981,201.436,203.443,206.395,210.85,215.881,220.336,224.791,227.743,229.948,231.955,235.906,240.361,244.816,246.823,251.278,255.733,257.74,262.195,264.4,268.855,276.307,278.314,280.771,285.271" svgx:width="0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.33,0.44,0.25,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.33,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.25,0.39,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.25,0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.5,0.25,0.5,0.83,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in the pure fampridine-responder subgroup (n=17), and by 3.3% in </text>
   <text y="444.909" x="49.606,54.061,58.516,62.971,65.923,68.875,72.826,76.282,80.737,85.192,89.647,94.102,98.053,101.005,104.461,106.711,111.139,114.091,118.546,123.577,128.032,132.487,135.439,137.689,142.117,146.068,150.523,157.48,161.935,165.886,168.838,172.789,177.244,179.494,183.922,186.379,190.834,193.084,197.512,199.969,204.424,208.375,210.625,215.053,219.508,221.965,225.916,229.867,233.818,238.273,242.728,244.978,249.406,251.863,254.815,258.766,262.717,265.174,272.131,276.082,280.537,282.994,285.244" svgx:width="0.5,0.5,0.5,0.33,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25,0.55,0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">non-responders (n=29) compared to the placebo treatment. </text>
   <text y="455.907" x="49.606,57.337,61.288,63.745,68.2,70.657,75.112,79.567,81.682,85.633,90.088,94.543,98.998,101.95,105.901,110.356,114.307,118.258,120.373,123.325,127.78,130.732,137.689,140.146,144.601,149.056,151.513,155.464,157.579,164.032,167.983,170.44,174.895,177.01,179.467,183.418,186.874,189.331,192.283,194.398,200.851,204.802,208.258,210.373,212.83,219.787,224.242,227.194,231.649,236.104,240.055,244.51,246.625,251.08,255.535,257.65,262.105,264.31,268.765,276.217,278.332,280.789,285.289" svgx:width="0.94,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.5,0.33,0.44,0.5,0.44,0.44,0.25,0.33,0.5,0.33,0.78,0.28,0.5,0.5,0.28,0.44,0.25,0.72,0.44,0.28,0.5,0.25,0.28,0.44,0.39,0.28,0.33,0.25,0.72,0.44,0.39,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.5,0.25,0.5,0.5,0.25,0.5,0.25,0.5,0.83,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Walking endurance (6-minute walk test) was improved by 8.5% in </text>
   <text y="466.905" x="49.606,52.063,56.518,60.469,62.719,65.284,67.741,72.196,74.653,78.604,81.061,83.311,85.876,90.331,94.786,99.241,103.696,106.153,110.104,112.561,115.018,119.473,123.928,126.133,128.38299999999998,130.957,135.412,139.867,142.072,146.527,153.979,156.229,158.803,161.26,165.715,167.965,170.53,173.482,177.433,180.889,185.344,189.799,194.254,198.709,202.66,205.612,209.068,211.273,213.523,216.088,220.039,224.494,228.949,231.199,233.773,238.228,240.433,244.888,252.34,254.59,257.155,259.612,264.067,266.317,268.882,273.337,277.792,282.247" svgx:width="0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.28,0.44,0.28,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.25,0.5,0.83,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the total population, 13.5% in responders, and 6.1% in non-</text>
   <text y="477.903" x="49.606,52.558,56.509,59.965,64.42,68.875,73.33,77.785,81.736,84.688,88.144,90.349,92.599,95.326,100.78,105.235,109.186,111.436,114.325,116.782,119.239,126.196,130.147,134.602,137.554,142.009,146.464,149.416,153.367,157.822,162.277,165.229,169.684,174.139,176.389,179.278,182.734,187.189,191.644,198.097,202.048,206.503,208.753,211.642,215.593,220.048,222.298,225.187,227.644,234.601,239.056,242.008,246.463,250.918,254.869,261.826,265.777,270.232,272.689,274.939,277.828,282.283,285.28" svgx:width="0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.28,0.28,0.78,0.44,0.5,0.33,0.5,0.5,0.33,0.44,0.5,0.5,0.33,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.55,0.44,0.5,0.25,0.55,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">responders. The timed-up-and-go showed an improvement of </text>
   <text y="488.901" x="49.606,54.061,56.266,60.721,68.173,70.189,72.646,77.101,79.117,81.574,86.029,89.98,91.996,94.453,98.908,101.365,105.316,107.773,109.789,114.244,118.699,123.154,127.609,130.066,134.017,136.474,138.931,143.386,147.841,150.046,152.062,156.517,159.469,161.485,165.607,170.062,172.267,176.722,184.174,186.19,188.647,193.102,195.118,198.07,202.021,205.477,209.932,214.387,218.842,223.297,227.248,230.2,233.656,235.672,239.623,244.078,248.533,250.549,254.5,256.516,262.969,267.424,270.376,273.832,277.783,282.238" svgx:width="0.5,0.25,0.5,0.83,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.5,0.83,0.25,0.28,0.5,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25,0.44,0.5,0.5,0.25,0.44,0.25,0.72,0.5,0.33,0.39,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">2.6% in the total population, of 11.2% in responders and a worsen-</text>
   <text y="499.899" x="49.606,52.063,56.518,60.973,62.908,67.363,70.315,72.241,75.193,79.648,87.1,89.035,91.492,95.947,97.882,102.337,106.792,111.247,114.199,117.151,121.102,124.558,129.013,133.468,137.923,142.378,146.329,149.281,152.737,154.942,156.868,161.827,164.284,168.235,170.692,173.149,177.604,182.059,186.01,188.962,193.417,195.352,199.303,203.758,208.213,210.139,214.594,219.049,223.504,227.455,234.412,236.869,240.82,242.755,249.712,253.663,257.614,261.07,265.525,268.477,272.428,275.884,277.81,282.265,285.262" svgx:width="0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.33,0.5,0.83,0.25,0.28,0.5,0.25,0.5,0.5,0.5,0.33,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25,0.25,0.56,0.28,0.44,0.28,0.28,0.5,0.5,0.44,0.33,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.44,0.78,0.28,0.44,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.39,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ing of -2% in non-responders. Stationary and dynamic measures of </text>
   <text y="510.897" x="49.606,53.062,55.519,59.47,63.925,66.382,68.839,71.296,73.753,78.208,80.467,84.922,87.379,91.834,94.093,98.548,103.003,105.46,107.719,110.671,114.622,119.077,123.028,126.979,129.436,131.695,135.151,137.608,142.063,146.518,148.975,151.927,154.384,158.335,162.286,166.741,169.198,171.457,175.408,179.863,183.814,188.269,192.724,196.675,200.131,202.39,204.847,209.302,213.757,218.212,222.163,226.114,230.569,232.828,237.283,241.738,243.997,246.949,250.9,257.857,262.312,265.264,267.721,272.176,274.633,279.088,283.039,285.289" svgx:width="0.39,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.33,0.44,0.5,0.44,0.44,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.39,0.25,0.28,0.5,0.5,0.5,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">stability did not reveal significant changes induced by fampridine. </text>
   <text y="521.895" x="49.606,56.059,60.01,62.467,64.924,67.264,71.719,74.671,79.126,82.078,84.535,86.992,90.943,94.399,96.739,100.69,105.145,109.6,113.056,115.513,118.969,121.426,123.883,128.338,132.793,135.133,139.588,142.54,144.88,151.837,156.292,158.749,161.206,163.663,168.118,170.575,174.526,176.866,181.321,183.778,188.233,192.184,199.141,203.092,205.549,208.006,211.957,214.297,218.248,222.703,227.158,229.498,233.953,236.41,240.865,244.816,247.273,249.73,253.681,256.021,260.476,264.427,267.379,271.33,278.287,282.238" svgx:width="0.72,0.44,0.28,0.28,0.25,0.5,0.33,0.5,0.33,0.28,0.28,0.44,0.39,0.25,0.44,0.5,0.5,0.39,0.28,0.39,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.5,0.28,0.5,0.44,0.78,0.44,0.28,0.28,0.44,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.5,0.44,0.28,0.28,0.44,0.25,0.5,0.44,0.33,0.44,0.78,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Gait profiles consisting of multiple kinematic and kinetic parame-</text>
   <text y="532.893" x="49.606,52.063,56.014,58.966,62.422,64.636,69.091,73.042,79.999,84.454,88.909,92.365,94.822,97.774,101.725,104.182,108.133,112.588,114.802,119.257,123.208,125.665,129.616,132.568,137.023,141.478,145.429,149.884,153.835,158.29,162.745,166.201,168.406,170.62,173.572,177.523,184.48,188.935,191.887,194.344,198.799,201.256,205.711,209.662,212.614,215.071,219.526,223.981,228.436,232.387,236.338,240.793,243.007,247.462,251.413,253.87,256.327,258.541,265.498,269.953,274.408,276.865,279.817,282.274" svgx:width="0.28,0.44,0.33,0.39,0.25,0.5,0.44,0.78,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.44,0.33,0.5,0.5,0.44,0.5,0.44,0.5,0.5,0.39,0.25,0.25,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.33,0.28,0.5,0.5,0.5,0.44,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.25,0.78,0.5,0.5,0.28,0.33,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ters demonstrated heterogeneous, fampridine-induced gait modifi-</text>
   <text y="543.891" x="49.606,53.557,57.508,59.965,62.422,66.877,71.332,74.788,76.993,78.928,84.382,88.837,92.788,94.885,99.34,101.797,104.587,107.539,111.49,114.442,118.393,122.848,125.305,127.762,131.713,134.17,136.267,140.218,144.673,148.624,153.079,157.534,161.485,164.941,167.038,169.495,173.95,176.047,178.504,182.959,186.91,189.007,193.462,197.413,199.87,202.327,204.424,208.879,212.83,215.287,217.744,221.695,224.647,229.102,231.199,235.15,242.107,246.562,251.017,255.472,257.569,262.024,265.975,268.432,270.889,274.84,279.295,281.752,285.253" svgx:width="0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.25,0.5,0.44,0.28,0.28,0.44,0.33,0.5,0.25,0.44,0.78,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cations. The differential changes in the gait pattern among patients </text>
   <text y="554.889" x="49.606,56.563,61.018,64.474,66.931,69.514,73.969,76.921,81.376,85.831,89.782,94.237,96.694,101.149,103.732,106.684,110.635,113.587,116.044,119.995,123.946,126.403,128.986,131.443,135.898,140.353,142.81,147.265,149.722,154.177,158.632,162.583,165.04,167.623,170.08,177.037,181.492,184.444,188.899,193.354,197.305,204.262,208.213,212.668,215.125,218.581,221.164,225.619,228.571,231.154,233.611,238.066,242.017,244.6,249.055,253.006,255.463,257.92,260.503,264.958,268.909,271.366,273.823,277.774,280.726,285.226" svgx:width="0.78,0.5,0.39,0.28,0.25,0.5,0.33,0.5,0.5,0.44,0.5,0.28,0.5,0.25,0.33,0.44,0.33,0.28,0.44,0.44,0.28,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.39,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.25,0.5,0.44,0.28,0.28,0.44,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">most probably reflect individual improvements of the gait pattern </text>
   <text y="565.887" x="49.606,54.061,58.012,62.467,66.418,70.873,75.328,77.785,82.24,86.695,88.9,93.355,97.81,100.015,102.472,106.927,110.878,113.083,116.539,120.994,124.945,128.896,131.353,134.305,136.762,140.713,142.918,147.373,151.324,154.276,156.733,160.684,163.141,165.598,169.054,171.259,175.714,178.666,180.871,184.822,188.773,192.724,197.179,199.384,203.839,207.79,210.247,212.704,216.655,221.11,223.567" svgx:width="0.5,0.44,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.5,0.44,0.33,0.28,0.44,0.28,0.28,0.39,0.25,0.5,0.33,0.25,0.44,0.44,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">depending on the specific deficits of each patient.</text>
   <text y="576.885" x="49.606,56.104,60.604,65.608,69.604,72.106,77.11,80.611,83.113,87.613,92.617,96.118,99.115" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="576.885" x="102.427,107.926,112.426,116.422,118.672,119.734,124.234,127.231,131.227,134.728,138.724,143.224,145.726,147.976,149.038,152.539,155.041,159.541,164.041,168.541,170.791,171.853,176.353,180.349,187.351,191.851,196.351,199.852,202.354,205.351,209.347,211.849,215.845,219.346,221.596,222.658,227.158,231.154,235.654,239.65,242.647,245.149,249.145,251.647,255.643,258.145,260.395,261.457,265.453,268.288,271.285,275.281,279.277,281.779,285.28" svgx:width="0.61,0.5,0.44,0.25,0.55,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.78,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.39,0.25,0.55,0.5,0.44,0.5,0.44,0.33,0.28,0.44,0.28,0.44,0.28,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The present study demonstrates beneficial effects </text>
   <text y="587.883" x="49.606,54.106,57.103,59.146,62.143,66.139,73.141,77.641,80.638,83.14,87.64,90.142,94.642,98.638,100.681,105.181,109.681,111.724,116.224,118.726,121.561,124.558,128.554,131.551,135.547,140.047,142.549,144.592,148.588,152.089,156.589,160.585,164.581,167.083,170.584,172.627,177.127,180.124,182.167,184.669,189.169,193.165,197.665,204.667,209.167,211.669,214.171,218.671,223.171,225.214,229.21,233.71,238.21,240.253,242.755,247.255,251.755,254.257,258.253,262.249,264.751,268.747,272.248,274.291,276.793,281.293,285.289" svgx:width="0.5,0.33,0.25,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.5,0.5,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.44,0.39,0.5,0.44,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.5,0.78,0.5,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.44,0.39,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of fampridine on different aspects of locomotion and indicates the </text>
   <text y="598.881" x="49.606,53.602,56.104,58.606,63.106,65.608,69.604,73.6,76.102,78.352,79.675,82.672,86.668,89.17,93.166,97.666,101.662,106.162,110.158,114.154,116.404,117.736,122.236,125.233,127.483,128.815,131.317,135.817,138.319,141.82,144.07,145.393,147.895,150.892,154.888,158.884,161.386,168.388,172.384,176.884,179.386,181.636,182.959,185.956,190.456,193.453,195.703,197.035,201.031,203.281,204.604,209.104,212.101,216.601,221.101,225.601,228.598,231.1,233.602,238.102,242.602,244.852,246.184,250.684,253.681,255.931,257.254,261.754,265.75,268.252,270.754,274.75,279.25,281.752,285.253" svgx:width="0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.28,0.39,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">clinical relevance of this treatment for a proportion of patients </text>
   <text y="609.879" x="49.606,56.104,58.606,61.108,65.608,67.858,75.859,80.863" svgx:width="0.72,0.28,0.28,0.5,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with MS.</text>
   <text y="636.879" x="49.606,55.105,59.605,64.105" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P912</text>
   <text y="647.877" x="49.606,55.105,59.101,63.097,67.597,72.097,74.599,78.595,83.599,87.595,91.591,93.841,98.341,101.338,103.588,108.592,113.092,115.594,120.598,122.848,125.35,130.354,132.604,140.101,145.105,147.607,150.604,153.106,158.11,160.612,164.608,166.858,170.359,174.355,176.857,180.853,184.849,189.349,192.85,195.352,198.853,201.85,204.1,208.6,210.85,218.347,223.351,225.853,228.85,231.352,235.348,239.344,244.348,247.345,251.341,255.337" svgx:width="0.61,0.44,0.44,0.5,0.5,0.28,0.44,0.56,0.44,0.44,0.25,0.5,0.33,0.25,0.56,0.5,0.28,0.56,0.25,0.28,0.56,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.33,0.25,0.5,0.25,0.83,0.56,0.28,0.33,0.28,0.44,0.44,0.56,0.33,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Prevalence of pain in multiple sclerosis: a multicenter </text>
   <text y="658.875" x="49.606,53.107,56.104,60.604,63.106,65.608,70.108,75.112,77.362,80.863,83.86,88.864,93.868" svgx:width="0.39,0.33,0.5,0.28,0.28,0.5,0.56,0.25,0.39,0.33,0.56,0.56,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Italian study</text>
   <text y="669.873" x="49.606,55.609,57.859,62.863,67.363,69.865,73.861,76.858" svgx:width="0.67,0.25,0.56,0.5,0.28,0.44,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">C Solaro</text>
   <text y="667.439" x="81.358" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="669.959" x="84.283,86.533,88.783,95.281,99.277,103.777,106.774,111.274,115.774,119.77,122.272,126.772,129.274,133.27,135.52,140.524,144.52,147.022,151.522,153.772,158.776,163.276,167.272,171.268,173.77,177.766,180.268,182.518,185.515,190.015,192.517,196.513,199.51,203.506,207.007,209.509,211.759,218.257,221.254,225.754,230.254,234.754,237.004,241.504,244.501,246.751,249.253,253.753,257.749" svgx:width="0.25,0.25,0.72,0.44,0.5,0.33,0.5,0.5,0.44,0.28,0.5,0.28,0.44,0.25,0.56,0.44,0.28,0.5,0.25,0.56,0.5,0.44,0.44,0.28,0.44,0.28,0.25,0.33,0.5,0.28,0.44,0.33,0.44,0.39,0.28,0.25,0.72,0.33,0.5,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, Neuropathic Pain Special Interest Group of the </text>
   <text y="680.957" x="49.606,52.603,55.105,59.101,61.603,64.105,68.101,72.601,74.851,81.349,85.345,89.845,92.842,97.342,99.844,104.344,108.844,111.346,115.342,119.338,121.84,124.09,129.094,133.594,137.59,140.092,144.088,146.59" svgx:width="0.33,0.28,0.44,0.28,0.28,0.44,0.5,0.25,0.72,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.56,0.5,0.44,0.28,0.44,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Italian Neurological Society</text>
   <text y="689.439" x="49.606" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="691.959" x="52.531,58.03,61.531,64.033,66.283,70.783,73.033,79.531,83.527,88.027,92.527,96.523,100.519,104.02,108.016,110.266,115.765,121.264,123.514,131.011,133.513,137.509,142.009,146.509,150.505,152.755,155.005,161.503,165.499,169.999,174.499,178.495,182.995,185.245,187.495,190.492,192.994,197.494,199.996" svgx:width="0.61,0.39,0.28,0.25,0.5,0.25,0.72,0.44,0.5,0.5,0.44,0.44,0.39,0.44,0.25,0.61,0.61,0.25,0.83,0.28,0.44,0.5,0.5,0.44,0.25,0.25,0.72,0.44,0.5,0.5,0.44,0.5,0.25,0.25,0.33,0.28,0.5,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Asl 3 Genovese PA Micone, Genova, Italy</text>
   <text y="718.959" x="49.606,55.609,60.109,64.105,69.109,73.609,77.443,81.943,86.947,91.951,96.955,99.952" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="718.959" x="102.355,110.356,114.856,117.358,119.86,122.362,126.862,129.364,133.36,135.763,140.767,144.763,147.265,151.261,154.258,158.758,162.259,164.761,168.262,170.665,173.662,181.663,186.667,189.664,192.067,194.569,198.07,200.473,204.469,206.872,210.868,215.368,218.365,222.865,227.365,229.867,233.863,236.266,238.768,243.268,246.265,248.767,252.763,259.765,266.767,270.763,273.265,277.765,280.762,285.262" svgx:width="0.89,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.56,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.28,0.39,0.25,0.44,0.25,0.44,0.5,0.33,0.5,0.5,0.28,0.44,0.25,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Multiple Sclerosis (MS) is a chronic inflammatory </text>
   <text y="729.957" x="49.606,54.106,58.102,65.104,69.604,73.6,76.102,78.604,83.104,87.1,89.602,92.104,96.604,101.104,103.354,104.407,108.907,111.409,114.91,118.906,122.902,126.403,130.399,132.649,133.702,138.202,141.199,143.449,144.502,148.498,152.494,156.994,159.496,162.493,166.489,168.991,171.241,172.294,176.794,180.79,183.787,188.287,192.787,197.287,200.788,203.038,204.091,207.592,212.092,215.593,218.095,222.091,229.093,231.343,232.396,235.393,241.396,247.894,252.898,255.895,258.145,260.395,261.448,264.445,268.945,271.195,272.248,280.249,285.253" svgx:width="0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.25,0.55,0.5,0.44,0.33,0.5,0.5,0.5,0.39,0.25,0.55,0.39,0.5,0.39,0.28,0.44,0.78,0.25,0.55,0.33,0.67,0.72,0.56,0.33,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">demyelinating disease of central nervous system (CNS). In MS </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M297.260 562.300 L328.510 562.300 "/>
  <g begin="text">
   <text y="77.103" x="297.26,301.76,305.756,308.258,312.758,315.251,318.248,322.244,326.744,329.741,333.737,337.238,341.234,345.734,348.236,351.737,354.23,358.73,363.23,367.226,369.719,374.219,377.216,379.709,382.211,386.711,390.707,393.2,400.202,404.702,408.203,410.705,413.198,417.194,421.694,428.696,435.698,440.198,444.698,447.191,450.692,455.192,462.194,466.694,469.196,473.696,480.698,484.199,486.449,488.942,492.938,496.439,498.941,501.443,508.445,512.441,514.943,518.939,523.439,525.932,528.434,532.934" svgx:width="0.5,0.44,0.28,0.5,0.25,0.33,0.44,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.39,0.25,0.5,0.5,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.78,0.5,0.39,0.28,0.25,0.44,0.5,0.78,0.78,0.5,0.5,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.25,0.44,0.39,0.28,0.28,0.78,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pain represents one of the most common symptoms, estimated to </text>
   <text y="88.101" x="297.26,301.76,305.756,309.752,314.252,317.249,319.337,321.839,326.339,328.427,332.927,337.427,344.924,347.012,349.514,354.014,356.102,360.602,365.102,372.599,374.687,379.187,382.184,384.272,388.772,392.768,395.27,397.772,401.768,406.268,408.77,412.271,414.521,416.609,421.613,425.609,428.111,432.611,434.699,438.2,442.7,447.2,451.7,454.697,459.197,466.199,470.195,473.696,475.784,479.78,482.777,486.773,488.861,495.863,499.859,502.361,506.861,509.363,513.863,515.951,519.947,522.449,526.445,529.946" svgx:width="0.5,0.44,0.44,0.5,0.33,0.25,0.28,0.5,0.25,0.5,0.5,0.83,0.25,0.28,0.5,0.25,0.5,0.5,0.83,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.56,0.44,0.28,0.5,0.25,0.39,0.5,0.5,0.5,0.33,0.5,0.78,0.44,0.39,0.25,0.44,0.33,0.44,0.25,0.78,0.44,0.28,0.5,0.28,0.5,0.25,0.44,0.28,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">occur in 29% to 86% of patients. Pain syndromes are mainly clas-</text>
   <text y="99.099" x="297.26,300.761,303.263,306.26,308.762,312.758,317.258,319.157,321.659,326.159,328.661,333.161,335.06,339.56,343.556,348.056,351.053,355.553,360.053,364.049,366.551,371.051,373.553,377.549,379.448,383.948,387.944,390.446,394.946,397.196,399.095,403.091,407.087,411.587,415.088,419.084,420.983,425.483,429.983,431.882,434.384,438.884,441.386,445.886,448.883,453.383,455.282,459.278,463.778,468.278,474.776,479.276,483.272,486.269,490.265,492.155,494.657,499.157,501.056,503.558,508.058,512.054,513.953,518.453,522.449,525.446,529.946" svgx:width="0.39,0.28,0.33,0.28,0.44,0.5,0.25,0.28,0.5,0.28,0.5,0.25,0.5,0.44,0.5,0.33,0.5,0.5,0.44,0.28,0.5,0.28,0.44,0.25,0.5,0.44,0.28,0.5,0.25,0.25,0.44,0.44,0.5,0.39,0.44,0.25,0.5,0.5,0.25,0.28,0.5,0.28,0.5,0.33,0.5,0.25,0.44,0.5,0.5,0.72,0.5,0.44,0.33,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sified into neuropathic pain, cause by injury anywhere in the nerv-</text>
   <text y="110.097" x="297.26,301.76,306.26,309.761,312.137,315.638,320.138,323.639,326.141,330.137,337.139,339.524,343.52,348.02,352.52,354.896,358.397,362.897,369.899,373.895,376.397,378.899,382.895,385.271,389.771,393.767,396.269,400.769,403.019,405.404,409.904,414.404,418.4,420.776,423.278,427.778,430.154,434.15,438.65,441.035,445.031,449.531,454.031,457.028,461.528,466.028,469.025,471.527,475.523,478.025,482.021,484.397,488.897,493.397,497.897,501.398,503.9,508.4,510.902,515.402,519.902,522.404,526.4,530.396,532.898" svgx:width="0.5,0.5,0.39,0.25,0.39,0.5,0.39,0.28,0.44,0.78,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.78,0.44,0.28,0.28,0.44,0.25,0.5,0.44,0.28,0.5,0.25,0.25,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.44,0.5,0.25,0.44,0.5,0.5,0.33,0.5,0.5,0.33,0.28,0.44,0.28,0.44,0.25,0.5,0.5,0.5,0.39,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ous system and somatic pain, due to an appropriate physiological </text>
   <text y="121.095" x="297.26,300.257,304.253,307.754,312.254,316.754,321.254,324.755,328.751,331.001,337.499,341.999,345.995,350.495,352.745,357.245,361.745,365.741,368.243,372.239,376.235,380.735,383.237,387.737,390.734,392.984,396.98,399.977,403.973,406.223,410.219,414.215,416.717,419.219,423.719,427.715,430.217,434.213,438.713" svgx:width="0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.25,0.72,0.5,0.44,0.5,0.25,0.5,0.5,0.44,0.28,0.44,0.44,0.5,0.28,0.5,0.33,0.25,0.44,0.33,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">response when nociceptor are activated.</text>
   <text y="132.093" x="297.26,304.262,309.266,312.263,316.259,320.255,323.252,325.754,330.254,334.25,337.751,340.748" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="132.093" x="342.935,348.434,352.934,356.93,359.117,363.113,365.615,372.617,374.804,379.304,382.301,384.479,386.981,391.481,395.477,397.664,401.165,403.667,408.167,412.667,417.167,419.354,421.856,425.357,427.544,430.046,434.546,436.733,440.729,444.23,447.731,451.727,455.228,458.729,460.907,463.409,467.909,471.905,474.092,478.592,481.589,485.585,489.086,493.082,497.582,501.578,505.574,507.752,512.252,515.249,517.436,521.936,525.932,528.434,532.934" svgx:width="0.61,0.5,0.44,0.25,0.44,0.28,0.78,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.28,0.39,0.25,0.28,0.5,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The aim of the study is to assess the presence of pain </text>
   <text y="143.091" x="297.26,299.762,304.262,306.503,314.504,319.508,321.749,326.249,330.245,332.747,335.249,339.245,343.745,346.247,349.748,351.998,354.239,356.741,361.241,363.482,367.478,369.719,376.721,381.221,383.723,386.225,388.727,392.723,396.719,401.219,403.721,406.718,410.714,412.955,416.951,419.948,424.448,427.949,431.45,434.447,437.948,441.944,445.94,448.442,450.944,455.444,459.944,463.94,466.442,468.683,472.184,474.686,479.186,483.686,488.186,490.427,494.423,498.923,503.423,505.664,508.166,510.668,514.169,516.41,519.407,523.403,525.905,529.901" svgx:width="0.28,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.28,0.5,0.25,0.44,0.25,0.78,0.5,0.28,0.28,0.28,0.44,0.44,0.5,0.28,0.33,0.44,0.25,0.44,0.33,0.5,0.39,0.39,0.33,0.39,0.44,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.28,0.39,0.25,0.33,0.44,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in MS patients, in a multicentre cross-sectional study and its rela-</text>
   <text y="154.089" x="297.26,299.762,302.264,306.764,311.264,314.765,319.265,321.767,326.267,328.517,335.015,337.517,340.019,344.519,346.769,350.765,353.015,356.516,361.016,365.012,369.008,371.51,374.507,377.009,381.005,383.255,387.755,391.751,394.253,398.753,401.003,405.503,410.003,413.999,417.5,420.002,422.504,427.004,431.504,436.004,440.0,442.502,445.499,449.495,451.745,454.742,461.24,467.738,472.238,475.235" svgx:width="0.28,0.28,0.5,0.5,0.39,0.5,0.28,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.5,0.44,0.28,0.5,0.25,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.25,0.33,0.72,0.72,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tionship with a specific pain questionnaire (DN4).</text>
   <text y="165.087" x="297.26,305.756,309.752,312.749,317.753,322.253,327.257,330.758,333.755" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="165.087" x="337.319,343.817,347.813,350.315,354.311,356.561,357.875,364.373,368.369,371.87,374.12,375.434,379.43,383.93,386.432,388.934,392.93,396.926,399.428,403.424,407.924,410.174,411.488,413.99,418.49,420.74,422.054,426.05,428.3,429.614,436.616,441.116,443.618,446.12,448.622,451.619,455.615,459.611,464.111,466.613,469.61,473.606,475.856,478.106,479.42,483.416,486.413,490.913,494.414,497.915,500.912,504.413,508.409,512.405,514.907,517.409,521.909,526.409,530.405,532.907" svgx:width="0.72,0.44,0.28,0.44,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.33,0.44,0.44,0.5,0.28,0.33,0.44,0.25,0.25,0.55,0.44,0.33,0.5,0.39,0.39,0.33,0.39,0.44,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Data was collected in a multi-centre, cross-sectional </text>
   <text y="176.085" x="297.26,300.761,303.263,307.763,312.263,316.763,319.013,320.003,322.505,327.005,331.505,336.005,338.507,343.007,345.509,350.009,354.509,356.759,357.749,362.249,364.499,365.489,367.991,370.493,374.489,376.991,379.493,383.489,387.989,390.239,391.229,399.23,404.234,406.484,407.474,411.47,415.466,419.966,422.468,425.465,429.461,432.962,435.212,436.202,440.702,444.203,446.705,451.205,455.705,457.955,458.945,462.941,465.191,466.181,469.178,473.174,477.17,481.166,484.163,486.665,491.165,494.162,497.159,501.155,505.151,509.147,511.397,512.387,515.888,518.39,521.387,525.887,529.883" svgx:width="0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.25,0.55,0.28,0.28,0.44,0.28,0.28,0.44,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.44,0.44,0.5,0.28,0.33,0.44,0.39,0.25,0.55,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.44,0.25,0.55,0.33,0.44,0.44,0.44,0.33,0.28,0.5,0.33,0.33,0.44,0.44,0.44,0.25,0.55,0.39,0.28,0.33,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">study involving 6 italian MS centres using a face-to-face struc-</text>
   <text y="187.083" x="297.26,299.762,304.262,307.259,311.255,315.755,318.599,323.099,327.599,331.595,335.096,337.598,340.1,344.6,349.1,353.6,357.596,360.098,363.095,367.091,369.935,373.931,378.431,385.433,389.933,392.435,394.937,398.933,403.433,406.277,410.777,415.277,418.121,422.117,424.961,429.461,433.457,437.957,440.954,445.454,447.956,452.456,456.956,459.458,462.959,465.461,467.711,470.555,475.055,479.555,484.055,486.899,491.399,495.395,497.897,500.399,504.395,508.895,511.397,514.898,517.4,521.396,525.392,529.892" svgx:width="0.28,0.5,0.33,0.44,0.5,0.25,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.25,0.44,0.5,0.78,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.5,0.25,0.44,0.25,0.5,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.28,0.39,0.28,0.25,0.25,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.28,0.44,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tured questionnaire compiled by a neurologist. 200 patients/cen-</text>
   <text y="198.081" x="297.26,299.762,302.759,306.755,310.256,312.236,318.734,321.236,323.738,328.238,330.218,334.214,336.194,340.694,343.196,347.192,351.692,356.192,360.692,364.193,366.695,370.196,372.176,376.676,379.673,381.653,389.654,394.658,396.638,401.138,404.135,406.115,412.118,415.115,420.119,422.099,426.599,431.099,435.095,438.092,440.072,444.068,446.048,450.548,454.544,457.541,460.043,464.543,469.043,471.023,475.523,478.52,480.5,485.0,486.98,493.982,498.482,502.982,505.484,509.984,513.485,515.465,521.963,525.959,528.956,532.952" svgx:width="0.28,0.33,0.44,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.5,0.33,0.25,0.89,0.56,0.25,0.5,0.33,0.25,0.67,0.33,0.56,0.25,0.5,0.5,0.44,0.33,0.25,0.44,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tres with a diagnosis of MS or CIS over a period of 6 months were </text>
   <text y="209.079" x="297.26,299.762,304.262,306.764,310.76,313.757,318.257,320.759,324.755,331.253,335.249,339.749,341.999,344.051,349.55,354.05,358.046,360.26,364.76,369.26,371.762,376.262,378.476,382.472,386.972,390.968,393.47,397.97,401.471,403.973,408.473,412.973,415.187,419.183,422.18,424.682,427.184,431.18,434.177,436.679,441.179,445.679,447.893,454.391,458.387,461.888,464.102,468.098,470.312,473.309,477.305,479.807,483.803,488.303,491.804,495.8,498.014,500.516,505.016,507.23,509.732,514.232,518.228,520.442,522.944,526.94,530.441,532.943" svgx:width="0.28,0.5,0.28,0.44,0.33,0.5,0.28,0.44,0.72,0.44,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.5,0.28,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.5,0.5,0.25,0.44,0.33,0.28,0.28,0.44,0.33,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.44,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.44,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">interviewed. The only exclusion criterion was a relapse in the last </text>
   <text y="220.077" x="297.26,304.262,308.762,313.262,315.764,320.264,322.514,325.349,329.849,333.845,336.842,341.342,344.339,348.335,350.585,353.42,355.922,360.422,364.418,366.668,369.503,374.003,377.999,382.499,385.001,389.501,394.001,396.503,401.003,405.503,407.753,410.588,415.088,418.085,420.335,423.17,425.672,430.172,434.168,436.418,439.253,442.754,445.256,449.756,454.256,458.171,460.421,462.671,465.344,470.843,475.343,479.339,481.589,484.424,488.924,493.424,497.42,500.921,503.423,505.925,510.425,514.925,519.425,523.421,525.923,528.92,532.916" svgx:width="0.78,0.5,0.5,0.28,0.5,0.25,0.55,0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">month before the beginning of the study. The questionnaire </text>
   <text y="231.075" x="297.26,299.762,304.262,308.258,310.76,315.26,319.76,323.756,328.256,330.218,334.718,338.714,345.716,350.216,354.716,357.713,361.709,366.209,370.709,373.211,377.207,379.169,383.669,387.665,390.167,394.163,396.413,398.375,402.875,406.871,410.867,413.864,415.826,420.326,423.323,425.285,428.786,433.286,440.288,444.788,447.29,451.79,458.792,460.754,465.254,469.754,473.255,477.251,479.753,481.715,485.711,490.211,494.711,496.673,501.173,503.675,507.671,512.171,516.671,521.171,524.672,527.174,530.675,532.925" svgx:width="0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.5,0.44,0.78,0.5,0.5,0.33,0.44,0.5,0.5,0.28,0.44,0.25,0.5,0.44,0.28,0.44,0.25,0.25,0.5,0.44,0.44,0.33,0.25,0.5,0.33,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.25,0.5,0.5,0.39,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">included demographic data, year of symptom onset and diagnosis, </text>
   <text y="242.073" x="297.26,302.759,307.259,311.759,315.755,320.255,324.755,328.751,333.251,335.501,336.347,342.845,345.347,348.848,352.844,357.344,359.846,362.348,364.85,367.352,371.852,374.102,374.948,379.952,382.454,386.45,388.952,393.452,396.953,399.203,400.049,405.053,409.049,413.045,415.547,419.543,421.793,422.639,425.636,431.135,437.633,442.637,447.641,450.638,452.888,455.138,455.984,459.98,462.482,464.984,469.484,471.986,475.982,479.978,482.48,484.73,485.576,489.572,494.072,498.572,501.569,505.07,509.066,511.316,513.566,514.412,520.415,524.411,528.407,532.907" svgx:width="0.61,0.5,0.5,0.44,0.5,0.5,0.44,0.5,0.25,0.55,0.72,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.56,0.28,0.44,0.28,0.5,0.39,0.25,0.55,0.56,0.44,0.44,0.28,0.44,0.25,0.55,0.33,0.61,0.72,0.56,0.56,0.33,0.25,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.25,0.55,0.67,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Expanded Disability Status Scale (EDSS), clinical course, Beck </text>
   <text y="253.071" x="297.26,302.264,306.26,310.256,312.758,316.754,319.004,321.254,323.189,329.687,334.187,339.686,344.186,348.686,350.936,353.186,355.121,361.619,364.121,367.622,371.618,375.614,379.115,383.111,385.361,387.296,394.298,398.798,403.298,405.8,408.797,413.297,415.799,420.299,424.799,427.049,428.984,431.486,434.483,438.479,442.475,444.977,451.979,455.975,460.475,462.977,465.227,467.477,469.412,473.912,477.908,480.41,484.91,487.16,489.095,491.597,496.097,500.093,503.09,507.086,511.586,515.501,517.751,520.001,521.936,524.438,528.938,532.934" svgx:width="0.56,0.44,0.44,0.28,0.44,0.25,0.25,0.55,0.72,0.5,0.61,0.5,0.5,0.25,0.25,0.55,0.72,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.78,0.5,0.5,0.28,0.33,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.55,0.5,0.44,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Scale, QoL36, Disease modifying treatment, pain therapy, the </text>
   <text y="264.069" x="297.26,303.758,310.256,314.756,317.006,318.095,322.595,327.095,331.091,334.592,337.094,339.596,344.096,348.596,353.096,357.092,359.594,362.591,366.587,368.837,369.926,372.923,377.423,380.42,382.67,383.759,388.259,390.761,393.596,396.593,400.589,403.586,407.582,412.082,414.584,417.086,421.082,423.584,425.834,426.923,431.423,433.925,437.921,442.421,446.921,451.421,454.922,457.424,460.925,463.175,464.264,468.764,471.761,474.011,475.1,479.6,483.596,486.098,490.598,492.848,493.937,497.438,501.938,506.438,510.938,513.935,518.435,525.437,529.433,532.934" svgx:width="0.72,0.72,0.5,0.25,0.55,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.5,0.25,0.55,0.39,0.5,0.5,0.5,0.33,0.5,0.78,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">DN4 questionnaire for differential diagnosis of pain syndromes </text>
   <text y="275.067" x="297.26,301.256,304.757,308.258,312.758,316.754,319.256,323.252,325.754,329.75,334.25,336.5,337.994,340.496,344.996,347.246,348.74,353.24,357.236,361.736,364.733,369.233,373.733,377.729,380.231,384.731,387.233,391.229,393.479,394.973,399.473,402.47,404.72,406.214,410.714,415.214,419.21,421.712,425.708,429.704,434.204,436.706,439.208,443.708,447.704,449.954,451.448,455.948,459.944,462.446,466.946,469.196,471.446,472.94,475.937,480.437,482.687,484.181,487.682,492.182,496.682,499.184,503.18,507.176,509.678,513.179,515.429,516.923,523.421,525.923,528.425,532.925" svgx:width="0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.5,0.33,0.5,0.5,0.44,0.28,0.5,0.28,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.44,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.5,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">associated to neuropathic or nociceptive pain. In subjects with </text>
   <text y="286.065" x="297.26,303.758,310.256,314.756,316.853,321.353,324.35,328.346,332.342,334.844,338.84,341.837,343.934,346.436,350.936,354.932,359.432,361.529,366.029,368.126,374.624,379.628,384.632,387.629,389.726,393.227,397.223,401.219,403.721,407.717,409.814,416.312,420.308,423.305,427.301,429.398,433.394,437.894,444.896,447.398,451.898,454.4,457.901,460.403,464.399,467.396,471.392,475.892,478.142,480.077,487.853,491.849,493.946,497.942,502.442,506.942,510.443,512.945,517.445,521.441,524.438,528.434,532.934" svgx:width="0.72,0.72,0.5,0.25,0.5,0.33,0.44,0.44,0.28,0.44,0.33,0.25,0.28,0.5,0.44,0.5,0.25,0.5,0.25,0.72,0.56,0.56,0.33,0.25,0.39,0.44,0.44,0.28,0.44,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.44,0.33,0.44,0.5,0.25,0.25,0.94,0.44,0.25,0.44,0.5,0.5,0.39,0.28,0.5,0.44,0.33,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">DN4 greater than 4 NPSI scale were administered. We considered </text>
   <text y="297.063" x="297.26,301.76,306.26,308.762,313.262,315.584,319.085,323.585,330.587,335.087,337.589,342.089,349.091,352.592,354.914,359.414,362.411,366.407,369.908,373.904,378.404,380.906,383.228,387.224,389.726,392.048,394.55,399.05,403.046,405.368,407.87,410.372,417.374,421.37,423.692,428.192,431.189,433.511,436.013,440.513,444.509,446.831,449.333,453.833,456.335,460.331,463.328,467.828,470.33,474.326,480.239,482.489,484.316,490.814,493.316,495.818,498.14,502.64,506.636,509.138,513.134,515.456,521.954,525.95,528.947,532.943" svgx:width="0.5,0.5,0.28,0.5,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.28,0.28,0.78,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.28,0.44,0.33,0.5,0.28,0.44,0.72,0.25,0.25,0.72,0.28,0.28,0.25,0.5,0.44,0.28,0.44,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">only symptoms present at the time of the interview. All data were </text>
   <text y="308.061" x="297.26,300.257,304.253,308.753,311.255,314.756,317.258,321.254,324.251,328.247,332.747,334.997,337.499,341.999,344.249,348.245,352.745,354.995,358.991,363.491,366.488,370.988,375.488,379.484,381.734,386.234,390.23,392.732,396.728,401.228,405.224,408.725,412.721" svgx:width="0.33,0.44,0.5,0.28,0.39,0.28,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.25,0.44,0.5,0.33,0.5,0.5,0.44,0.25,0.5,0.44,0.28,0.44,0.5,0.44,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">registered in an ad-hoc database.</text>
   <text y="319.059" x="297.26,303.758,307.754,311.255,316.259,318.761,321.758,325.259,328.256" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="319.059" x="332.81,339.308,343.808,346.31,348.56,350.864,355.364,358.361,360.611,362.915,367.415,371.915,376.415,380.915,383.165,385.469,388.97,393.47,397.97,400.472,404.468,408.464,410.966,414.467,416.717,419.021,421.523,426.023,428.525,432.521,435.518,440.018,442.52,446.516,453.014,457.01,461.51,463.76,466.01,468.314,474.812,478.808,481.805,485.801,488.051,490.355,494.855,499.355,503.855,506.105,508.409,511.406,515.402,522.404,526.4,528.902,532.898" svgx:width="0.72,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.5,0.28,0.44,0.72,0.44,0.5,0.25,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Out of 1253 subjects interviewed, were 835 female </text>
   <text y="330.057" x="297.26,300.257,304.757,309.257,311.507,316.007,323.504,326.501,329.084,333.08,337.58,342.08,344.672,349.172,353.672,358.172,360.755,367.757,371.753,374.255,378.251,380.834,383.831,388.331,392.831,395.081,399.581,402.173,409.67,412.667,414.917,417.5,424.502,428.498,432.494,436.994,439.577,443.573,448.073,452.069,454.661,461.159,465.155,468.656,471.239,475.739,480.239,482.489,486.989,489.572,494.072,498.068,502.064,505.061,508.562,510.812,513.395,520.397,524.393,528.389,532.889" svgx:width="0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.25,0.78,0.44,0.28,0.44,0.25,0.33,0.5,0.5,0.25,0.5,0.25,0.83,0.33,0.25,0.25,0.78,0.44,0.44,0.5,0.25,0.44,0.5,0.44,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.25,0.78,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(66,6%) and 418 male (33,4 %), mean age was 33,9 years, mean </text>
   <text y="341.055" x="297.26,301.76,304.262,307.763,311.759,315.755,319.256,323.252,325.502,327.779,332.279,336.779,339.776,343.772,346.274,348.776,353.276,357.776,360.026,362.303,366.803,369.053,371.33,375.83,379.826,383.822,386.819,390.32,392.57,394.82,397.097,401.597,406.097,410.597,412.847,415.124,418.121,422.621,427.121,429.371,433.871,441.368,444.365,446.615,448.892,452.393,456.893,461.393,463.895,467.891,471.887,474.389,477.89,480.14,482.417,486.917,490.913,495.413,497.663,499.94,502.937,506.933,509.435,513.431,517.931,521.432,523.934,528.434,532.934" svgx:width="0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.39,0.25,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.55,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">disease duration 8 years, 916 (73,1%) subjects had relapsing </text>
   <text y="352.053" x="297.26,300.257,304.253,311.255,313.757,316.259,318.761,321.263,325.763,330.263,332.513,333.719,338.219,340.721,344.222,348.218,352.214,355.715,359.711,361.961,363.167,367.163,371.663,376.163,379.16,382.661,386.657,388.907,391.157,392.363,396.863,401.363,405.863,408.113,409.319,412.316,416.816,421.316,423.566,428.066,435.563,438.56,440.81,442.016,448.514,452.51,455.507,459.503,461.753,462.959,466.46,470.456,474.452,478.952,483.452,487.952,491.948,494.945,499.445,501.695,502.901,507.401,510.398,514.898,519.398,522.395,526.391,529.892" svgx:width="0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.44,0.44,0.5,0.5,0.5,0.44,0.33,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">remitting disease course, 248 (19,8%) were secondary progres-</text>
   <text y="363.051" x="297.26,300.761,303.263,307.763,311.759,314.009,316.259,317.726,322.226,326.726,328.976,330.443,333.44,337.94,340.19,344.69,352.187,355.184,357.434,358.901,365.399,369.395,372.392,376.388,378.638,380.105,384.605,387.602,390.104,397.106,401.102,404.099,408.599,410.849,412.316,416.816,419.813,424.313,428.813,431.81,435.806,439.307,442.808,445.31,449.81,453.806,456.056,457.523,461.519,466.019,470.519,472.769,474.236,478.736,483.236,485.486,486.953,489.95,494.45,496.7,501.2,508.697,511.694,513.944,515.411,521.909,525.905,528.902,532.898" svgx:width="0.39,0.28,0.5,0.44,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.5,0.25,0.5,0.83,0.33,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.33,0.28,0.78,0.44,0.33,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.5,0.25,0.5,0.83,0.33,0.25,0.55,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sive, 55 (4,4%) were primary progressive and 30 (2,4%) were </text>
   <text y="374.049" x="297.26,303.263,306.26,311.264,313.514,315.737,323.738,327.734,331.73,336.23,338.453,343.952,350.45,355.454,360.458,362.681,366.182,370.178,374.678,377.675,381.671,383.885,390.383,394.379,397.88,400.103,404.603,406.853,411.353,413.603,415.826,420.326,424.826,429.326,431.549,435.05,439.55,444.05,446.552,450.548,454.544,457.046,460.547,462.77,465.767,470.267,474.767,477.017,481.517,489.014,492.011,494.225,497.222,501.218,505.718,510.218,513.215,515.717,519.713,524.213,526.436,530.432,532.934" svgx:width="0.67,0.33,0.56,0.25,0.25,0.89,0.44,0.44,0.5,0.25,0.61,0.72,0.56,0.56,0.25,0.39,0.44,0.5,0.33,0.44,0.25,0.72,0.44,0.39,0.25,0.5,0.25,0.5,0.25,0.25,0.5,0.5,0.5,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CIS. Mean EDSS score was 3.2. 458 subjects (36,6%) reported at </text>
   <text y="385.047" x="297.26,299.762,303.758,307.754,311.255,313.757,315.647,320.147,324.647,328.643,330.533,335.033,339.029,341.531,346.031,349.028,353.528,356.03,357.92,361.421,365.921,372.923,377.423,379.925,384.425,391.427,393.677,395.567,400.067,403.064,404.954,411.452,415.952,420.452,427.454,429.344,433.844,438.344,442.844,444.734,451.232,453.734,456.236,460.736,462.626,469.124,475.622,480.122,485.063,489.563,491.453,495.953,500.453,504.449,506.951,510.947,514.943,519.443,521.945,524.447,528.947,532.943" svgx:width="0.28,0.44,0.44,0.39,0.28,0.25,0.5,0.5,0.44,0.25,0.5,0.44,0.28,0.5,0.33,0.5,0.28,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.25,0.25,0.5,0.33,0.25,0.72,0.5,0.5,0.78,0.25,0.5,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.72,0.5,0.55,0.5,0.25,0.5,0.5,0.44,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">least one painful symptom, of whom 173 with DN4≥4 nociceptive </text>
   <text y="396.045" x="297.26,301.76,305.756,308.258,312.758,315.008,319.238,323.234,327.734,332.234,334.484,338.714,343.214,347.714,352.214,354.464,358.694,365.192,367.694,370.196,374.696,376.946,381.176,387.674,394.172,398.672,403.748,405.998,410.228,414.728,416.978,421.208,425.708,429.704,434.204,437.201,441.701,446.201,450.197,452.699,457.199,459.701,463.697,465.947,470.177,472.679,477.179,481.679,485.675,487.925,492.155,495.152,500.651,505.151,509.147,512.144,519.146,521.648,524.15,526.652,530.648,532.898" svgx:width="0.5,0.44,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.72,0.72,0.5,0.56,0.25,0.55,0.5,0.25,0.55,0.5,0.44,0.5,0.33,0.5,0.5,0.44,0.28,0.5,0.28,0.44,0.25,0.55,0.28,0.5,0.5,0.44,0.25,0.55,0.33,0.61,0.5,0.44,0.33,0.78,0.28,0.28,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pain and 284 with DN4&lt; 4 neuropathic type (Lhermitte, </text>
   <text y="407.043" x="297.26,302.444,305.441,307.943,312.443,316.439,323.441,325.943,330.443,334.439,336.941,339.191,343.943,350.441,354.437,358.937,361.934,365.93,368.432,372.932,375.434,379.43,381.68,383.93,388.682,394.181,398.681,405.179,409.175,412.172,414.422,419.174,421.676,424.178,431.18,435.68,438.677,440.927,443.177,447.929,455.93,460.43,462.932,465.434,467.936,472.436,476.432,479.429,481.931,485.927,488.429,492.425,496.925,499.175,503.927,507.923,512.423,516.419,518.921,523.421,526.922,529.424,532.925" svgx:width="0.61,0.33,0.28,0.5,0.44,0.78,0.28,0.5,0.44,0.28,0.25,0.55,0.72,0.44,0.5,0.33,0.44,0.28,0.5,0.28,0.44,0.25,0.25,0.55,0.61,0.5,0.72,0.44,0.33,0.25,0.55,0.28,0.28,0.78,0.5,0.33,0.25,0.25,0.55,0.89,0.5,0.28,0.28,0.28,0.5,0.44,0.33,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Trigeminal Neuralgia, Lower limb). Multivariated analysis </text>
   <text y="418.041" x="297.26,300.761,305.261,309.761,316.259,320.255,324.755,327.518,331.514,334.277,337.778,340.28,344.78,349.28,351.782,354.779,357.281,361.277,365.273,369.773,372.275,375.038,379.538,382.04,384.875,387.872,391.868,394.865,398.861,403.361,407.357,411.353,414.116,417.113,421.613,424.61,427.373,430.37,434.87,437.867,440.63,444.626,449.126,453.122,455.372,458.135,463.634,470.132,475.136,480.14,482.39,485.153,489.653,492.155,495.656,499.652,503.648,507.149,511.145,513.908,518.408,522.908,525.905,529.901" svgx:width="0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.44,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.33,0.5,0.33,0.25,0.33,0.5,0.33,0.25,0.44,0.5,0.44,0.25,0.25,0.61,0.72,0.56,0.56,0.25,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.5,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">showed a significant difference for for age, EDSS, disease dura-</text>
   <text y="429.039" x="297.26,299.762,302.264,306.764,311.264,313.784,317.78,322.28,326.78,329.3,333.8,336.302,339.803,343.799,347.795,351.296,355.292,357.812,361.808,366.308,370.808,373.805,377.306,381.302,383.822,387.818,392.318,396.818,399.338,402.839,407.339,411.335,415.331,417.833,420.83,423.332,427.328,429.848,433.349,437.345,441.341,443.843,447.839,450.359,453.86,457.856,462.356,465.353,469.349,471.869,474.866,479.366,482.363,484.883,489.383,493.379,495.881,500.381,502.901,507.401,511.397,513.899,520.397,524.393,528.389,532.889" svgx:width="0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.39,0.44,0.44,0.28,0.44,0.25,0.39,0.44,0.5,0.33,0.44,0.25,0.33,0.5,0.33,0.25,0.5,0.44,0.28,0.5,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion and disease course and specific scale score for pain between </text>
   <text y="440.037" x="297.26,301.76,305.756,308.258,312.758,315.008,315.845,319.841,324.341,328.841,331.091,331.928,336.428,340.928,343.178,344.015,348.515,352.511,355.013,359.513,361.763,362.6,367.1,370.097,374.597,379.097,383.597,385.847,388.097,388.934,391.931,396.431,398.681,399.518,404.018,408.014,410.516,413.018,417.014,421.514,424.016,427.517,429.767,430.604,437.102,439.604,442.106,446.606,448.856,449.693,456.191,462.689,467.189,469.439,470.276,475.352,480.428,484.928,487.178,489.428,490.265,496.763,501.767,506.771,509.768,512.018,512.855,517.355,521.351,525.851,528.101,528.938,532.934" svgx:width="0.5,0.44,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.72,0.72,0.5,0.25,0.55,0.56,0.56,0.5,0.25,0.25,0.55,0.72,0.56,0.56,0.33,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pain and no pain group. In patients with DN4 &gt;=4, NPSI had a </text>
   <text y="451.035" x="297.26,304.262,308.258,312.254,316.754,319.004,323.504,326.501,328.751,333.251,337.751,340.001,346.499,349.001,351.503,356.003,358.253,362.753,366.749,369.251,373.751,377.747,381.248,383.498,386.495,390.491,394.991,399.491,401.993,406.493,410.993,413.243,417.743,421.739,424.241,430.739,434.735,438.731,443.231,445.481,449.981,452.231,456.227,460.727,465.227,467.477,471.977,476.477" svgx:width="0.78,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.44,0.28,0.5,0.44,0.39,0.25,0.33,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mean of 41 with values ranging between 5 and 97.</text>
   <text y="462.033" x="297.26,303.758,308.258,313.262,317.258,319.76,324.764,328.265,330.767,335.267,340.271,343.772,346.769" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="462.033" x="349.73,355.229,359.729,362.231,365.732,367.982,368.693,372.194,374.696,379.196,383.696,388.196,390.446,391.157,395.657,400.157,404.657,408.653,411.65,414.152,416.654,421.154,425.15,428.651,430.901,431.612,434.114,438.614,442.61,444.86,445.571,448.568,452.564,455.066,459.062,463.562,467.558,472.058,476.054,480.05,482.3,483.011,487.511,490.508,492.758,493.469,497.969,501.965,504.467,508.967,511.217,511.928,514.43,518.93,521.18,521.891,524.393,528.893,532.889" svgx:width="0.61,0.5,0.28,0.39,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.44,0.33,0.28,0.28,0.5,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">This study underlines the relevance of pain in the </text>
   <text y="473.031" x="297.26,301.256,303.758,306.26,310.76,313.262,317.258,321.254,323.756,326.006,326.726,331.226,333.728,337.229,339.731,344.231,347.228,351.728,353.978,354.698,359.198,362.195,364.445,365.165,373.166,378.17,380.42,381.14,385.136,389.636,394.136,396.386,397.106,399.608,404.108,408.104,410.354,411.074,413.576,420.578,425.078,429.578,432.575,435.077,439.073,443.573,447.569,451.565,453.815,454.535,457.037,461.537,463.787,464.507,469.007,472.508,476.504,478.754,479.474,483.47,485.72,486.44,489.941,494.441,498.437,502.433,504.935,507.932,510.434,514.43,516.68,517.4,521.9,525.896,528.398,532.898" svgx:width="0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.5,0.28,0.39,0.28,0.5,0.33,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.89,0.56,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.44,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.39,0.44,0.25,0.55,0.44,0.25,0.55,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.55,0.5,0.44,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">clinical history of MS and the importance to use a specific pain </text>
   <text y="484.029" x="297.26,301.76,306.26,310.256,313.757,316.259,318.761,323.261,327.761,332.261,336.257,338.759,341.756,345.752,348.002,351.503,356.003,359.999,364.499,366.749,370.745,374.246,376.496,382.994,389.492,393.992" svgx:width="0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.25,0.39,0.5,0.44,0.5,0.25,0.44,0.39,0.25,0.72,0.72,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">questionnaire such as DN4.</text>
   <text y="517.032" x="297.26,302.759,307.259,311.759" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P913</text>
   <text y="528.03" x="297.26,303.758,307.754,311.255,314.252,316.754,320.75,324.251,327.752,330.002,332.504,336.5,341.0,344.501,346.751,350.252,354.752,359.756,364.76,368.756,373.256,380.753,384.749,386.999,389.249,392.75,395.252,399.248,403.244,408.248,410.498,415.502,420.506,425.006,427.508,430.01,433.007,437.507,439.757,444.257,449.261,454.265,456.515,461.519,465.515,470.519,474.515,478.511,482.012,485.513,488.015,492.515,497.519,499.769,502.271,507.275" svgx:width="0.72,0.44,0.39,0.33,0.28,0.44,0.39,0.39,0.25,0.28,0.44,0.5,0.39,0.25,0.39,0.5,0.56,0.56,0.44,0.5,0.83,0.44,0.25,0.25,0.39,0.28,0.44,0.44,0.56,0.25,0.56,0.56,0.5,0.28,0.28,0.33,0.5,0.25,0.5,0.56,0.56,0.25,0.56,0.44,0.56,0.44,0.44,0.39,0.39,0.28,0.5,0.56,0.25,0.28,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Restless legs syndrome, sleep quality and depression in </text>
   <text y="539.028" x="297.26,301.256,305.252,307.754,312.254,317.258,320.759,323.261,328.265,332.765,335.015,339.011,343.007,350.504,353.006,356.003,359.0,361.502,366.506,371.006,373.256,380.753,385.757,388.259,391.256,393.758,398.762,401.264,405.26,407.51,411.011,415.007,417.509,421.505,425.501,430.001,433.502,436.004,439.505,441.755,446.255,451.259,456.263,458.513,462.509,467.009,471.005,475.001,478.997,481.499,485.999,488.996,491.498,495.998,501.002,504.503" svgx:width="0.44,0.44,0.28,0.5,0.56,0.39,0.28,0.56,0.5,0.25,0.44,0.44,0.83,0.28,0.33,0.33,0.28,0.56,0.5,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.25,0.5,0.56,0.56,0.25,0.44,0.5,0.44,0.44,0.44,0.28,0.5,0.33,0.28,0.5,0.56,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">relapsing remitting multiple sclerosis and correlations </text>
   <text y="550.026" x="297.26,303.758,306.26,309.257,314.261,316.511,320.507,324.503,328.499,332.999,335.501,339.497,343.997,346.499,348.749,352.25,357.254,359.756,364.76,369.26,371.762,374.012,378.008,382.508,386.504,391.508,393.758,398.762,403.262,410.759,415.259,419.759" svgx:width="0.72,0.28,0.33,0.56,0.25,0.44,0.44,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.39,0.56,0.28,0.56,0.5,0.28,0.25,0.44,0.5,0.44,0.56,0.25,0.56,0.5,0.83,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">with cervical spinal cord damage</text>
   <text y="561.024" x="297.26,303.758,306.008,312.506,315.008,317.51,320.012,324.512" svgx:width="0.72,0.25,0.72,0.28,0.28,0.28,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">O Kilinc</text>
   <text y="558.583" x="328.507" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="561.103" x="331.432,333.682,335.932,341.935,344.185,350.188,354.688,357.19,361.69" svgx:width="0.25,0.25,0.67,0.25,0.67,0.5,0.28,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, B Bulut</text>
   <text y="558.583" x="364.192" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="561.103" x="367.117,369.367,371.617,378.115,383.614,385.864,391.867,395.863,398.86" svgx:width="0.25,0.25,0.72,0.61,0.25,0.67,0.44,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, AZ Berk</text>
   <text y="558.583" x="403.36" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="561.103" x="406.285,408.535,410.785,415.789,418.039,424.537,429.037,433.033,437.029,441.529,445.525" svgx:width="0.25,0.25,0.56,0.25,0.72,0.5,0.44,0.44,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Akcabey</text>
   <text y="558.583" x="450.024" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="561.103" x="452.949,455.199,457.449,462.948,465.198,470.202,474.198,476.7,481.2,485.7" svgx:width="0.25,0.25,0.61,0.25,0.56,0.44,0.28,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, E Salduz</text>
   <text y="558.583" x="489.696" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="561.103" x="492.621,494.871,497.121,503.619" svgx:width="0.25,0.25,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, H </text>
   <text y="572.101" x="297.258,303.756,307.752,310.254,314.754,317.751,322.251,326.247" svgx:width="0.72,0.44,0.28,0.5,0.33,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Ozturkcu</text>
   <text y="569.583" x="330.748" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="572.103" x="333.673,335.923,338.173,344.671,346.921,353.419,357.919,361.915" svgx:width="0.25,0.25,0.72,0.25,0.72,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, K Agan</text>
   <text y="569.583" x="366.415" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="580.581" x="297.262" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="583.103" x="300.185,307.682,312.182,315.683,322.181,326.681,330.182,334.682,336.932,343.43,347.93,350.432,354.428,358.424,361.925,365.426,367.928,370.43,374.426,376.676,383.174,387.674,391.175,395.675,398.177,400.679,405.179,407.681,409.931,412.181,418.679,422.675,427.175,431.675,435.176,437.678,444.176,448.172,452.672,455.174,457.424,461.924,464.426,466.676,472.679,476.675,481.175,484.676,489.176,491.678,496.178,500.678,504.674,506.924" svgx:width="0.83,0.5,0.39,0.72,0.5,0.39,0.5,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Marmara University Hospital, Department of Neurology, </text>
   <text y="594.101" x="297.26,300.257,303.758,306.26,310.76,315.26,319.76,324.26,326.762,329.012,331.262,336.266,340.766,344.267,348.263,352.259,356.255,358.505" svgx:width="0.33,0.39,0.28,0.5,0.5,0.5,0.5,0.28,0.25,0.25,0.56,0.5,0.39,0.44,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Istanbul, Turkey, </text>
   <text y="591.583" x="360.754" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="594.103" x="363.679,371.176,375.676,379.177,385.675,390.175,393.676,398.176,400.426,406.924,411.424,413.926,417.922,421.918,425.419,428.92,431.422,433.924,437.92,440.17,447.667,451.663,456.163,458.665,462.661,467.161,469.663,471.913,477.412,481.912,485.908,490.408,492.91,495.412,499.408,501.658" svgx:width="0.83,0.5,0.39,0.72,0.5,0.39,0.5,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.61,0.5,0.44,0.5,0.28,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Marmara University Medical Faculty, </text>
   <text y="605.101" x="297.259,300.256,303.757,306.259,310.759,315.259,319.759,324.259,326.761,329.011,331.261,336.265,340.765,344.266,348.262,352.258" svgx:width="0.33,0.39,0.28,0.5,0.5,0.5,0.5,0.28,0.25,0.25,0.56,0.5,0.39,0.44,0.44,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Istanbul, Turkey</text>
   <text y="632.101" x="297.259,303.262,307.762,311.758,316.762,321.262,325.096,329.596,334.6,339.604,344.608,347.605" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="632.101" x="351.421,356.92,361.42,365.416,368.413,372.409,374.659,376.225,378.727,382.228,384.478,386.044,390.04,392.29,393.856,398.356,401.353,405.853,412.351,414.853,419.353,423.853,426.103,427.669,430.171,434.671,437.173,441.169,444.166,448.162,451.663,454.165,456.415,457.981,460.483,464.983,467.233,468.799,471.796,475.792,479.293,481.795,484.297,488.293,491.794,495.295,497.545,499.111,501.613,505.609,510.109,513.61,515.86,517.426,520.927,525.427,529.927" svgx:width="0.61,0.5,0.44,0.33,0.44,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.25,0.55,0.5,0.33,0.5,0.72,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.44,0.39,0.28,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.44,0.39,0.28,0.28,0.44,0.39,0.39,0.25,0.55,0.28,0.44,0.5,0.39,0.25,0.55,0.39,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">There is a growing interest in restless legs syn-</text>
   <text y="643.099" x="297.259,301.759,304.756,309.256,316.258,320.254,322.504,324.808,327.805,333.808,339.307,344.311,347.308,349.558,351.862,355.858,360.358,364.858,367.108,369.412,372.913,375.415,379.411,383.407,387.907,390.157,392.461,396.961,399.463,402.964,407.464,410.461,414.961,418.957,421.954,425.455,427.705,430.009,432.511,437.011,439.261,441.565,448.567,453.067,455.569,458.071,460.573,465.073,467.575,471.571,473.821,476.125,479.626,483.622,486.124,490.12,493.117,497.617,501.118,503.62,507.121,509.371,511.675,514.672,522.673,527.677,530.674,532.924" svgx:width="0.5,0.33,0.5,0.78,0.44,0.25,0.55,0.33,0.67,0.61,0.56,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.28,0.44,0.44,0.5,0.25,0.55,0.5,0.28,0.39,0.5,0.33,0.5,0.44,0.33,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.89,0.56,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">drome (RLS) and sleep disorders in multiple sclerosis (MS). </text>
   <text y="654.097" x="297.259,302.263,306.763,309.265,313.765,317.761,320.263,322.513,323.395,327.391,331.891,334.888,339.388,341.638,342.52,345.517,350.521,356.524,359.521,361.771,362.653,367.153,371.149,378.151,382.147,386.647,390.643,392.893,393.775,396.772,400.768,405.268,408.265,412.261,415.762,419.758,424.258,426.76,430.261,432.511,433.393,437.389,439.639,440.521,444.022,446.524,451.024,455.524,458.026,461.023,463.525,467.521,471.517,476.017,478.519,480.769,481.651,484.648,487.15,490.651,495.151,497.401,498.283,501.28,505.276,509.272,511.774,516.274,519.271,521.521,522.403,525.4,529.9,532.897" svgx:width="0.56,0.5,0.28,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.33,0.5,0.25,0.55,0.33,0.56,0.67,0.33,0.25,0.55,0.5,0.44,0.78,0.44,0.5,0.44,0.25,0.55,0.33,0.44,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.33,0.28,0.39,0.5,0.25,0.55,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.55,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Spinal cord (SC) damage represents a significant risk factor for </text>
   <text y="665.095" x="297.259,303.262,308.761,313.765,316.321,318.823,323.323,325.879,333.88,338.884,341.44,345.94,349.936,352.438,354.94,358.936,363.436,365.938,369.439,371.995,374.497,378.997,381.553,385.054,389.05,393.55,397.546,400.543,404.539,407.041,409.597,413.098,415.6,420.1,424.6,427.102,431.098,434.599,436.849,439.405,445.903,450.403,456.901,460.897,465.397,469.393,472.03,474.28,476.836,479.338,483.838,487.834,490.39,493.387,497.383,499.885,503.881,506.383,508.885,513.385,517.885,521.386,525.886,528.388,532.888" svgx:width="0.67,0.61,0.56,0.25,0.28,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.5,0.25,0.39,0.44,0.5,0.44,0.33,0.44,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.72,0.5,0.72,0.44,0.5,0.44,0.33,0.25,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">RLS in MS patients in several studies. However, the relationship </text>
   <text y="676.093" x="297.259,301.759,305.755,308.257,314.755,318.751,322.747,327.247,329.497,335.5,340.999,346.003,348.253,352.249,356.749,361.249,363.499,368.503,374.506,376.756,379.258,383.254,386.755,389.257,393.757,398.257,401.758,404.008,406.51,411.01,413.26,421.261,426.265,428.515,431.017,434.518,436.768,440.269,442.771,445.273,447.775,450.277,452.527,457.027,461.527,465.523,468.025,472.021,476.017,478.519" svgx:width="0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.67,0.61,0.56,0.25,0.44,0.5,0.5,0.25,0.56,0.67,0.25,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.28,0.5,0.25,0.89,0.56,0.25,0.28,0.39,0.25,0.39,0.28,0.28,0.28,0.28,0.25,0.5,0.5,0.44,0.28,0.44,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">between RLS and SC lesions in MS is still unclear.</text>
   <text y="687.091" x="297.259,304.261,309.265,312.262,316.258,320.254,323.251,325.753,330.253,334.249,337.75,340.747" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="687.091" x="342.988,348.487,352.987,356.983,359.224,363.22,365.722,372.724,374.965,379.465,382.462,384.703,387.205,391.705,394.207,397.708,399.949,403.45,405.952,410.452,414.952,419.452,421.693,424.195,427.696,429.937,432.439,436.939,439.18,441.682,446.182,450.682,454.678,458.179,460.681,463.183,467.683,471.679,474.181,478.177,480.418,482.92,487.42,491.416,493.657,497.158,499.66,503.656,507.652,512.152,514.393,518.893,523.393,527.389,529.891" svgx:width="0.61,0.5,0.44,0.25,0.44,0.28,0.78,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.39,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.28,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.39,0.28,0.44,0.44,0.5,0.25,0.5,0.5,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The aim of this study is to investigate the sleep qual-</text>
   <text y="698.089" x="297.259,299.761,302.263,306.763,309.013,310.282,313.279,318.283,324.781,327.778,330.028,331.297,335.293,339.793,344.293,346.543,347.812,350.314,354.814,358.81,361.06,362.329,366.829,369.826,373.822,378.322,382.318,384.82,388.816,393.316,397.312,401.308,403.558,404.827,409.327,412.324,414.574,415.843,421.846,427.345,432.349,434.599,435.868,439.864,444.364,448.864,451.114,452.383,456.883,460.879,465.379,468.376,472.372,475.873,479.374,481.876,486.376,490.876,493.126,494.395,496.897,501.397,503.647,504.916,509.416,513.412,515.914,518.417,522.412,526.912,529.414,532.915" svgx:width="0.28,0.28,0.5,0.25,0.55,0.33,0.56,0.72,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.44,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.61,0.56,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ity (SQ) and the prevalence of RLS and depression in patients </text>
   <text y="709.087" x="297.259,303.757,306.259,308.761,313.261,315.511,318.508,322.504,325.006,329.002,333.502,337.003,339.505,344.005,348.505,350.755,353.752,357.748,364.75,367.252,369.754,372.256,374.758,379.258,383.758,386.008,393.01,397.51,400.012,402.514,405.016,409.516,412.018,416.014,418.264,421.765,425.761,428.263,432.259,435.256,439.756,443.257,445.759,449.26,451.51,454.508,460.51,466.513,474.514,479.518,482.516" svgx:width="0.72,0.28,0.28,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.67,0.67,0.89,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with relapsing remitting multiple sclerosis (RRMS).</text>
   <text y="720.085" x="297.259,305.755,309.751,312.748,317.752,322.252,327.256,330.757,333.754" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="720.085" x="337.066,343.069,345.319,346.381,348.883,353.383,355.885,359.881,362.383,364.633,365.695,370.195,373.192,375.442,376.504,381.004,385.504,387.754,388.816,394.819,400.822,408.823,413.827,416.077,417.139,421.639,425.635,428.137,430.639,434.635,439.135,441.637,445.138,447.388,448.45,451.447,455.947,460.447,462.697,463.759,466.756,470.752,477.754,481.75,484.252,488.248,491.749,493.999,496.249,497.311,501.811,506.311,508.561,509.623,516.625,520.621,523.123,527.119,530.62,532.87" svgx:width="0.72,0.25,0.55,0.28,0.5,0.28,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.67,0.67,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.5,0.5,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.44,0.39,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.44,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A total of 93 RRMS patients (67 females, 26 males, </text>
   <text y="731.083" x="297.259,304.261,308.257,312.253,316.753,319.021,323.017,327.517,331.513,333.781,338.281,342.781,345.031,349.531,351.799,356.74,359.008,363.508,365.758,370.258,373.255,375.523,382.021,386.017,389.014,393.01,395.278,399.274,403.774,406.771,411.271,413.773,416.275,420.271,424.771,427.039,429.541,434.041,436.309,438.811,443.311,447.307,449.575,453.076,455.578,460.078,464.578,468.493,470.743,472.849,478.348,482.848,486.844,489.112,493.612,496.114,500.11,504.61,509.11,513.61,517.111,519.613,523.114,525.382,529.882,532.879" svgx:width="0.78,0.44,0.44,0.5,0.25,0.44,0.5,0.44,0.25,0.5,0.5,0.25,0.5,0.25,0.55,0.25,0.5,0.25,0.5,0.33,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mean age 34,5 ± 8,6) were enrolled in the study. The diagnosis of </text>
  </g>
 </g>
</svg>
